A detailed history of Symphony Financial, Ltd. Co. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 17,802 shares of BMY stock, worth $967,004. This represents 0.15% of its overall portfolio holdings.

Number of Shares
17,802
Previous 13,051 36.4%
Holding current value
$967,004
Previous $542,000 69.93%
% of portfolio
0.15%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$39.66 - $51.75 $188,424 - $245,864
4,751 Added 36.4%
17,802 $921,000
Q2 2024

Jul 17, 2024

BUY
$40.25 - $52.99 $239,165 - $314,866
5,942 Added 83.58%
13,051 $542,000
Q1 2024

Apr 17, 2024

SELL
$47.98 - $54.4 $180,116 - $204,217
-3,754 Reduced 34.56%
7,109 $385,000
Q4 2023

Jan 18, 2024

BUY
$48.48 - $57.85 $285,207 - $340,331
5,883 Added 118.13%
10,863 $557,000
Q3 2023

Nov 07, 2023

BUY
$57.89 - $64.73 $11,230 - $12,557
194 Added 4.05%
4,980 $289,000
Q2 2023

Jul 12, 2023

BUY
$63.71 - $70.74 $41,793 - $46,405
656 Added 15.88%
4,786 $306,000
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $788 - $894
12 Added 0.29%
4,130 $286,000
Q4 2022

Jan 26, 2023

BUY
$68.48 - $81.09 $5,683 - $6,730
83 Added 2.06%
4,118 $0
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $48 - $28,507
-371 Reduced 8.42%
4,035 $289,000
Q2 2022

Jul 18, 2022

BUY
$72.62 - $79.98 $7,842 - $8,637
108 Added 2.51%
4,406 $345,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $43,712 - $52,414
711 Added 19.82%
4,298 $332,000
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $1,126 - $1,312
-21 Reduced 0.58%
3,587 $222,000
Q3 2021

Oct 12, 2021

SELL
$59.17 - $69.31 $111,535 - $130,649
-1,885 Reduced 34.32%
3,608 $219,000
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $80,978 - $88,185
1,308 Added 31.25%
5,493 $369,000
Q1 2021

Apr 15, 2021

BUY
$59.34 - $66.74 $248,337 - $279,306
4,185 New
4,185 $259,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Symphony Financial, Ltd. Co. Portfolio

Follow Symphony Financial, Ltd. Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.